All posts by : Adherium

With nearly 40 published peer-reviewed journal articles under its belt, Adherium is hoping that the latest clinical data which underlines the ability of the company’s Smartinhaler to improve outcomes for.

Gabriella Rogers reports on a new combination treatment for asthma sufferers. Click here to watch the story.  

Chief Executive Officer and Co-founder, Garth Sutherland is scheduled to speak at the Australia Biotech Invest 2016 conference being to be held on 26-27 October, 2016 at the Melbourne Convention Centre, in.

Melbourne, Australia, 13 June 2016: Adherium Limited (ASX: ADR), a global leader in digital health technologies that address sub- optimal medication use in chronic disease, today announced that AstraZeneca will.

5,700 Adherium Smartinhaler™ devices plus associated software and communications technologies to be supplied through to 2018 Study in New Zealand, Australia, the United Kingdom & Italy Supply agreement with leading.

August 5, 2015 – Australians and New Zealanders have an opportunity to invest in a highly promising digital health technology company that substantially improves medication adherence and patient health outcomes.

July 23, 2015 – New Zealand-based Adherium (NZ) Limited has entered a long term partnership with international pharmaceutical leader AstraZeneca in what the company believes is a world-first commercial arrangement.

Adherium (NZ) Limited (formerly Nexus6) has received ISO 13485 medical device quality management system certification for operations at its New Zealand head office.   ISO 13485 is an international quality.